Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time

By LabMedica International staff writers
Posted on 23 May 2024

Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. These conditions are caused by the clumping together of the smallest building blocks in the body that disrupts vital functions. Within our cells, numerous interactions and exchanges among proteins and other molecules occur naturally, allowing our bodies to function properly. However, errors in these processes can lead to protein clumps that impair functionality, underpinning a variety of neurodegenerative disorders affecting the brain, including Alzheimer's and dementia. Understanding why this clumping occurs and how to treat it has remained elusive, largely due to a lack of adequate tools to study these phenomena. Researchers have now introduced a groundbreaking tool that can find these tiny protein clumps in microscopy images and lead to improved understanding and treatments of diseases like cancer, Alzheimer's, and Parkinson's.

Scientists at the University of Copenhagen (Copenhagen, Denmark) have developed a machine learning algorithm capable of observing protein clumping in real time under a microscope. This algorithm is capable of automatically identifying and monitoring the critical characteristics of the clumped-up building blocks responsible for Alzheimer's and other neurodegenerative diseases—a task previously unachievable. It can detect protein clumps as small as a billionth of a meter in microscopy images and categorize these clumps by their shape and size while tracking their development. The physical appearance of these clumps significantly influences their function and behavior within the body, whether detrimental or beneficial.

Going forward, this algorithm will simplify the process of discovering why clumps form, thereby aiding the development of new medications and therapies to fight these debilitating disorders. The researchers are actively using this tool in experiments with insulin molecules, which, when clumped, lose their ability to regulate blood sugar effectively. The tool allows for the observation of how these clumps change when exposed to various compounds, paving the way to potentially halt or alter them into less harmful or more stable forms. The team is optimistic about the tool's potential to facilitate drug development once these tiny building blocks are precisely identified. They anticipate that their efforts will initiate the gathering of more comprehensive knowledge regarding the shapes and functions of proteins and molecules. The algorithm is accessible as open-source software on the internet for use by scientific researchers and others interested in exploring the clumping of proteins and other molecules.

"In just minutes, our algorithm solves a challenge that would take researchers several weeks. That it will now be easier to study microscopic images of clumping proteins will hopefully contribute to our knowledge, and in the long term, lead to new therapies for neurodegenerative brain disorders," said PhD Jacob Kæstel-Hansen, who led the research team behind the algorithm.

Related Links:
University of Copenhagen

Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
H.pylori Test
Humasis H.pylori Card
New
Silver Member
ACTH Assay
ACTH ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.